Indian Council of Medical Research
Indian Council of Medical Research ▸ Facts ▸ Comments ▸ News ▸ Videos
India records 10,064 new COVID cases in last 24 hours
Credit: ANI Duration: 01:12Published
India records 13,788 new COVID cases in last 24 hours
Credit: ANI Duration: 01:26Published
COVID-19: Total cases cross 1.05 crore-mark in India
Credit: ANI Duration: 01:52Published
COVID-19: Active cases in India dip to 2,10,l06
Credit: ANI Duration: 01:45Published
‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist
Credit: HT Digital Content Duration: 04:36Published
Covishield and Covaxin are safe, assures ICMR scientist
Credit: ANI Duration: 02:29Published
Covaxin's immunity will address mutants too: ICMR scientist
Credit: ANI Duration: 01:24Published
India records 15,968 new COVID cases in last 24 hours
Credit: ANI Duration: 01:33Published
COVID-19: Active cases dip to 2.16 lakh in India
Credit: ANI Duration: 01:39Published
India records 16,311 new COVID cases in last 24 hours
Credit: ANI Duration: 01:48Published
India reports 18,645 new COVID-19 infections, 19,299 recoveries in last 24 hours
Credit: ANI Duration: 01:38Published
COVID: Active cases dip to 2.25 lakh in India
Credit: ANI Duration: 01:39Published
India's COVID-19 recoveries cross 1 crore mark
Credit: ANI Duration: 01:42Published
Everyone will give their consent for vaccine, there'll be no placebo: ICMR
Credit: ANI Duration: 01:47Published
You Might Like
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet studyIndia's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the..
Vaccine drive accelerates, doses reach far corners of IndiaWhile SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
No irregularity in approval to Covaxin: ICMRIn an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2..
All-India vaccine rollout set for next week: GovtThe government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
During pandemic, vaccine's restricted use considered based on safety, immunogenicity data: ICMR chief
Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chiefThe Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and..
From abroad, Rahul directing Cong rumour-mongering: BJPIntensifying attack on Congress for questioning the DCGI’s approval to Covid vaccines, BJP on Monday said Rahul Gandhi, while on a vacation abroad, choreographed rumour-mongering by enlisting his..
ICMR says clinical trial shows COVAXIN is 'safe'Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR.
In a 1st, NIV-Pune isolates, cultures Covid's UK variantPune's National Institute of Virology (NIV) has isolated and cultured the new UK variant of SARS-CoV2, the Indian Council of Medical Research (ICMR) said on Saturday underlining that no other country..
India successfully cultures UK-variant of Sars-CoV-2: ICMR
ICMR-RMRC study on use of saliva for SARS-CoV-2 test shows promise
Careless use of therapies may lead to mutations, says ICMRThe Indian Council of Medical Research (ICMR) warned against non-judicious use of therapies that have not been established for treating Covid-19 because it can lead to immune pressure on SARS-CoV2..
Non-judicious use of therapies for Covid-19 leads to virus mutations: ICMR chief"Those therapies which are being touted as 'anti-viral' or 'anti-Covid therapies' and they have do not have benefits established in a scientific research paper, those therapies should not be used as..
3rd serosurvey to cover health workers: ICMRA third Covid-19 serosurvey by the Indian Council of Medical Research is set to assess the infection’s spread among health workers in India. The survey, which began on Thursday, is expected to..
Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah NaiduThey discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans..
Also reported by •DNA
Indian vaccine Covaxin has drawn global attention: ICMRThe Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, "India's indigenous vaccine against..
New coronavirus strain not found in samples tested in India, says ICMR-NARI directorThe director said that 7 to 11 sub-types of coronavirus are already known but not each one that is identified needs to be seen with panic.
DNA Analysis: How air pollution is bigger threat than we perceiveICMR has released statistics on deaths from pollution. According to these figures, in 2019, 16 lakh deaths have occurred due to pollution in India.
‘Pollution killed 1.7m in India in 2019, behind 18% of all deaths’Air pollution killed nearly 1.7 million people in India in 2019, accounting for an alarming 17.8% of all deaths in the country in the year, a new paper written as a collaborative effort by Indian..
ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19This comes as India's COVID-19 caseload rose to 99.79 lakh with 22,890 new infections being reported in a day.
ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma CentreIndian Council of Medical Research (ICMR) Director General Balram Bhargava is undergoing treatment for Covid-19 at the AIIMS Trauma Centre here, official sources said on Friday. Bhargava, who is also a..
Entire population may not need to be vaccinated: ICMRDr Bhargava and health secretary Rajesh Bhushan also said a decision is yet to be taken on whether those who have been infected by the disease and recovered need to be administered the vaccine. While..
‘Adverse event’ won’t affect vaccine rollout plan: GovernmentICMR director general Dr Balram Bhargava said adverse events occur with drugs, vaccines or any other health interventions. It is the role of the regulator after collating all the data to ascertain or..
PM Modi reaches Hyderabad to visit Bharat Biotech plantPM Modi will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the AF base, officials said. Covid-19 vaccine, Covaxin, being developed..
ICMR nod for CCMB's dry swab testing for Covid-19
India had estimated 74 million Covid-19 infections by August: ICMR's 2nd national serosurvey
13 crore Covid-19 tests done so far, cumulative positivity rate falling steadily: Health ministryAccording to the Indian council of medical research (ICMR), over 13.06 crore samples have been tested till November 20 with 10,66,022 being tested on Friday. Higher volumes of testing eventually lead..
Troubling trend: India test numbers fall, RAT share remains highWidespread use of RAT, in some cases up to 90% of all tests, has raised fears that a large number of positive cases could be missed. As per the ICMR protocol, every positive report from RAT can be..
Covid-19: Indiscriminate use of Convalescent Plasma Therapy not advisable, says ICMR
First time since August, daily tests below 9 lakh for 3 daysDaily Covid-19 cases in India rose to over 38,000 on Tuesday after dropping below 30,000 the previous day but the number of tests conducted in the country continued to remain low for the fourth day..
Third wave in Covid-19 cases has come now in Delhi: ICMRA third spike in Covid-19 cases has come now in Delhi which is showing more cases than before, with factors like pollution, cold weather and festivals playing a major role in the rise of the..
India-made COVID-19 vaccine could be launched as early as this month, know whenBharat Biotech, a private company that is developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), had earlier hoped to launch it only in the second quarter of next year.
Bharat Biotech to launch Covaxin in Q2 2021Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company official said. The..
BCG vaccine could help elderly fight Covid: ICMRThe nearly century-old Bacille Calmette-Guérin (BCG) vaccine can help the elderly fight off infections such as Covid-19, a study by the Indian Council of Medical Research has said. The researchers..
Some evidence shows children could be Covid spreaders: ICMR
COVID-19 vaccine: Phase 3 of human trial of Covaxin to begin at Odisha's SUM hospital soonA total of 21 medical institutes were selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted.
ICMR issues advisory for use of Feluda paper strip testThe paper-strip uses cutting-edge CRISPR gene-editing technology to identify and target the genetic material of SARS-CoV-2, the virus that causes Covid-19 in less than an hour. As claimed by the..
'Tum mujhe vote do,hum tumhe vaccine denge': Shiv Sena's Sanjay Raut on BJP's Bihar polls manifestoThe Bharatiya Janata Party (BJP) on Thursday released its manifesto for three-phased Bihar elections and promised that after approval of coronavirus vaccine from ICMR, every person in the state will..
India crosses 10 cr-mark in conducting Covid-19 tests: ICMR
ICMR issues advisory on CRISPR technology-based SARS CoV-2 testThe Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General of India for Covid-19 detection. As..
ICMR could derail world’s largest trial
Odisha, Goa swear by plasma therapy despite ICMR’s note
Free Covid vaccine, 19 lakh jobs: BJP releases Bihar manifestoBharatiya Janata Party (BJP) on Thursday released its manifesto for the three-phased Bihar elections promising to distribute the coronavirus vaccine free of cost once approved by the ICMR, and also..
IIT Kharagpur's 'Covirap' diagnostic machine gets ICMR certification
Plasma therapy is likely to be off Covid treatment protocol: ICMR
Virus can hit recovered Covid patients once antibodies start depleting: ICMR
‘Post Trials’ data, ICMR needs to revise Covid-19 drug regimen’
ICMR: Three re-infection cases in India, 24 globally
DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a..
No benefit of plasma therapy arresting mortality in moderate to severe Covid-19 cases: ICMRAddressing a press conference here Bhargava said, "An ICMR study has clearly established no benefit of plasma therapy in arresting mortality in moderate to severe cases of Covid-19. Following a cue..